Table 3.
CRP Level Stratified Associations between BMI and ciruclating 25-OHD from Unadjusted and Multivariable-adjusted Linear Regression models among Cancer Survivors Aged 20 years or Older from the NHANES 2001–2010 (n=1305)
| Circulating 25-OHD (nmol/L) | ||
|---|---|---|
| Unadjusted beta coefficient (95% CI) | Adjusteda beta coefficient (95% CI) | |
|
Low risk CRP level (<1.0 mg/L), n=348 |
||
| BMI (kg/m2) | ||
| <25.0 | reference | reference |
| 25.0–29.9 | −0.10 (−7.26 to 7.05) | −1.33 (−9.33 to 6.67) |
| ≥ 30 | −3.62 (−11.42 to 4.17) | −5.31 (−12.66 to 2.04) |
| P-trend | 0.46 | 0.20 |
|
| ||
| Moderate risk CRP level (1.1–3.0 mg/L), n=498
|
||
| BMI (kg/m2) | ||
| <25.0 | reference | reference |
| 25.0–29.9 | −2.23 (−9.16 to 4.69) | −1.64 (−7.86 to 4.58) |
| ≥ 30 | −8.05 (−15.62 to −0.47) | −9.90 (−16.45 to −3.36) |
| P-trend | 0.04 | 0.004 |
|
| ||
| High risk CRP level (3.1–9.9 mg/L), n=459
|
||
| BMI (kg/m2) | ||
| <25.0 | reference | reference |
| 25.0–29.9 | −6.87 (−13.34 to −0.40) | −8.63 (−14.33 to −2.92) |
| ≥ 30 | −9.46 (−16.96 to −1.95) | −11.61 (−18.17 to −5.05) |
| P-trend | 0.03 | 0.004 |
a
Adjusted for age, sex, race, smoking status, season of blood draw, and dietary vitamin D supplement use.